SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. - Wikidata - wikimedia - TriplyDB

SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.

SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.

http://www.wikidata.org/entity/Q34439858

about

Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents Larvae of the small white butterfly, Pieris rapae, express a novel serotonin receptor Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor The GR127935-sensitive 5-HT(1) receptors mediating canine internal carotid vasoconstriction: resemblance to the 5-HT(1B), but not to the 5-HT(1D) or 5-ht(1F), receptor subtype Selective 5-HT receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions A novel potential therapeutic avenue for autism: design, synthesis and pharmacophore generation of SSRIs with dual action Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.Molecular cloning, sequence analysis and pharmacological properties of the porcine 5-HT(1D) receptor Polysynaptic excitatory postsynaptic potentials that trigger spasms after spinal cord injury in rats are inhibited by 5-HT1B and 5-HT1F receptors 5-HT inhibits synaptic transmission in rat subthalamic nucleus neurons in vitro.Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.Pathophysiology of Migraine: A Disorder of Sensory Processing.Serotonin activates angiogenic phosphorylation signaling in human endothelial cells.Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan Serotonin modulates the response of embryonic thalamocortical axons to netrin-1.A61603-induced contractions of the porcine meningeal artery are mediated by alpha1- and alpha2-adrenoceptors.The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat.Diurnal variation in 5-HT1B autoreceptor function in the anterior hypothalamus in vivo: effect of chronic antidepressant drug treatment.5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor Involvement of 5-HT1B and 5-HT1D receptors in sumatriptan mediated vasocontractile response in rabbit common carotid artery.On the role of 5-HT1B/1D receptors in modulating transmission in a spinal reflex pathway in the decerebrated rabbit.5-HT moduline: an endogenous inhibitor of 5-HT(1B/1D)-mediated contraction in pulmonary arteries.Agonist-directed trafficking explaining the difference between response pattern of naratriptan and sumatriptan in rabbit common carotid artery.Mechanisms involved in the regulation of bovine pulmonary vascular tone by the 5-HT1B receptor.Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses.Postsynaptic 5-HT1B receptors modulate electroshock-induced generalised seizures in rats.Serotonin-1B receptor-mediated inhibition of [(3)H]GABA release from rat ventral tegmental area slices.5-Hydroxytryptamine-induced vasodilator responses in the hindquarters of the anaesthetized rat, involve beta2-adrenoceptors.Effect of sympathetic and parasympathetic mediators on the release of calcitonin gene-related peptide and prostaglandin E from rat dura mater, in vitro.Comparative analysis of pharmacological properties of xanomeline and N-desmethylclozapine in rat brain membranes.Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target.Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.

P2860

Q28140526-1A6B3998-D73B-402D-8243-18CECFCD2CCB Q28247281-48D2EE58-9762-4F7A-84AF-1156B828155E Q28343925-2311438D-6B99-4F63-80F4-FCF17B26ED62 Q28354155-7F30A5BD-35FC-4BE8-A71D-E8F662BBBB27 Q28566207-9B56BF4C-1882-4D13-8529-1F6B9E92047D Q30486707-C42DB8DE-4775-4582-AC33-A4891BA20A1D Q33857458-F8438224-1D4D-409C-8B22-75CF231FECBC Q33924947-99B212A1-56A6-4CAD-BCEF-819548348960 Q34264341-9A0B2F4B-0128-42ED-A7AD-5A92A56C0B31 Q34529520-0B48B3AB-320C-493C-8DA4-16C1D433B348 Q35028460-DE698F9F-12AF-4DB6-84B1-A0A0CE7CA33F Q35042842-15D26F48-FDF8-40A4-9A50-D96F6F025D21 Q35160555-AF641E53-9B36-49EB-BB51-8AE56CD14BD4 Q36517898-9329AD75-8098-4B76-B844-FCDFFBF35111 Q38961181-1B774497-F9E5-473F-97B3-13D299627620 Q39127073-19CADFC2-9712-451A-ABF0-D5585BF4A879 Q39334060-6895F656-BE8D-4A45-A134-99097CF105ED Q39810939-343A950E-8B52-491F-ACAD-B8397617D0B3 Q40142792-AC19EB88-F861-4CC5-A1A3-8F3EC15FF5F6 Q40232077-96D36709-A199-4E4F-A8A0-7835B92C868F Q40645909-4269FED0-2BC0-48B6-B6EA-3CEEB55C7878 Q41772237-CAC2A089-9F93-4B52-937F-3FB3DD83093A Q41824586-20C0E114-B551-4571-9377-E31530250361 Q41840257-CF8DE1F0-EC40-4A89-9FA3-1F07EF12C608 Q41878888-6429C437-7B50-4F9F-B009-79116140F110 Q41972338-5CB88DCD-F62B-4215-BF45-0CB893E8A10B Q42710489-F84D57FB-CF13-4A3B-AFFC-E88DE7BADB4C Q42914141-70BBAEA5-A183-4076-942B-01395EC78CCE Q43192569-057F37F9-B60B-44D7-94E7-01C0F3E8F7A0 Q43261547-A8D1D68D-0E7E-4A0F-B8F3-54B3DB81C6D7 Q43809113-22BE4F87-852E-45BD-8147-8934A50AEFCC Q44648357-CC6D8F3A-CCF3-44F5-8DFB-BA6E34A5EA86 Q46939653-00849266-A247-4A85-ACD5-452E6F298D43 Q48600420-060BAAD7-021F-43D7-AA28-50EBEE5950F8 Q51139025-C5F19EF7-5D5B-4C80-838B-E6438E7EA801 Q55296093-B93DD5BB-0DB9-4380-A2BA-3535E7894343

P2860

SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.

http://www.wikidata.org/entity/Q34439858

description

1997 nî lūn-bûn

@nan

1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

SB-216641 and BRL-15572--compo ...... h5-HT1B and h5-HT1D receptors.

@ast

SB-216641 and BRL-15572--compo ...... h5-HT1B and h5-HT1D receptors.

@en

SB-216641 and BRL-15572--compo ...... h5-HT1B and h5-HT1D receptors.

@nl

type

label

SB-216641 and BRL-15572--compo ...... h5-HT1B and h5-HT1D receptors.

@ast

SB-216641 and BRL-15572--compo ...... h5-HT1B and h5-HT1D receptors.

@en

SB-216641 and BRL-15572--compo ...... h5-HT1B and h5-HT1D receptors.

@nl

prefLabel

SB-216641 and BRL-15572--compo ...... h5-HT1B and h5-HT1D receptors.

@ast

SB-216641 and BRL-15572--compo ...... h5-HT1B and h5-HT1D receptors.

@en

SB-216641 and BRL-15572--compo ...... h5-HT1B and h5-HT1D receptors.

@nl

P1433

Q34439858-897CDE4D-5B8A-4765-B097-B3E5A7DFF4DD

P1476

Q34439858-AB470E6A-030E-42E3-9DF1-313F277AFC1A

P2093

Q34439858-309DBBDB-9E00-49A0-ADFE-8C4E18CEA7E6

Q34439858-54D68CBC-D5C2-4C6C-AC0A-4926EA1AB5C6

Q34439858-60FEC577-8AA8-4460-A316-EF448C83E271

Q34439858-68B89604-AC77-44F0-B727-0B683017C7D0

Q34439858-830B9E35-F9E2-4ACD-8C5C-41DC19D45E46

Q34439858-8BF393FB-C3C0-499D-93B8-8BEB6577D515

Q34439858-9C99C574-58A2-48D2-9936-8C268A263A23

Q34439858-9CCAFDAD-522C-4FDB-950A-C27D95D9D2A1

Q34439858-DAEAFC3A-51B5-431B-BA63-12D60CAA00A9

Q34439858-F4583809-6850-4BA0-9CD5-6E6EE7C45852

P2888

Q34439858-E670E047-96FC-4488-8E5C-F28639EF61A1

P304

Q34439858-28EFE1E7-40E6-47C1-8ADB-894544696479

P31

Q34439858-680C2319-8EFF-41A8-9EA4-F406ED1D306C

P356

Q34439858-29E7F59F-75F7-4832-9E9E-AC691D3A3B02

P433

Q34439858-354FC290-2D0D-4160-AF62-C44346453315

P478

Q34439858-25C324A7-8621-4916-AF46-DE24828D1CE5

P577

Q34439858-1217B1B2-2F4D-47C0-8200-2681F3D2836E

P6179

Q34439858-D596E39F-B224-4C88-AC78-86A844D8D250

P698

Q34439858-E7CDBFA5-AE91-4501-8AB2-AF638C306F05

P921

Q34439858-5360A9B8-20B9-4083-BC2D-A89F65316FCC

P356

P1433

Naunyn-Schmiedeberg's Archives of Pharmacology

P1476

SB-216641 and BRL-15572--compo ...... h5-HT1B and h5-HT1D receptors.

@en

P2093

Burton MJ

http://www.w3.org/2001/XMLSchema#string

Collin LJ

http://www.w3.org/2001/XMLSchema#string

Duckworth M

http://www.w3.org/2001/XMLSchema#string

Gaster L

http://www.w3.org/2001/XMLSchema#string

Göthert M

http://www.w3.org/2001/XMLSchema#string

Jones BJ

http://www.w3.org/2001/XMLSchema#string

Middlemiss DN

http://www.w3.org/2001/XMLSchema#string

Price GW

http://www.w3.org/2001/XMLSchema#string

Roberts C

http://www.w3.org/2001/XMLSchema#string

Watson JM

http://www.w3.org/2001/XMLSchema#string

P2888

P304

312-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/PL00005056

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

356

http://www.w3.org/2001/XMLSchema#string

P577

1997-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051745238

http://www.w3.org/2001/XMLSchema#string

P698

9303567

http://www.w3.org/2001/XMLSchema#string

P921